66.93
0.00
(0.00%)
At close: January 14 at 3:00:00 PM EST
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | 1 | 5 | 5 |
| Avg. Estimate | -- | 19.45M | 265.77M | 236.2M |
| Low Estimate | -- | 19.45M | 256.7M | 216M |
| High Estimate | -- | 19.45M | 270M | 250.3M |
| Year Ago Sales | -- | -- | 96.72M | 265.77M |
| Sales Growth (year/est) | -- | -- | 174.77% | -11.13% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CMOPF | -- | -- | -- | -- |
| S&P 500 | 8.58% | 11.41% | 13.97% | 13.43% |
Related Tickers
JNJd.XC
GILD34.SA Gilead Sciences, Inc.
275.40
+0.51%
600436.SS PIENTZEHUANG
207.12
-0.98%
SNW.F Sanofi
93.42
-1.77%
SNW.HM Sanofi SA
93.13
-2.19%
BAYA.BE Bayer AG
4.9200
-1.60%
BIIB34.SA Biogen Inc.
144.30
-4.57%
GS71.DE GSK plc
15.46
-3.10%
ZEG.DE AstraZeneca PLC
126.35
-2.05%
PFE.DU Pfizer Inc
25.68
-1.23%